Bill H.266 establishes a new subchapter in Vermont law regarding the 340B Drug Pricing Program, which aims to regulate the interactions between drug manufacturers, covered entities, and contract pharmacies. The bill defines key terms such as "340B contract pharmacy," "340B covered entity," and "340B drug," and prohibits manufacturers from denying or interfering with the acquisition and delivery of 340B drugs to covered entities. It also mandates that manufacturers provide discounts at the time of purchase rather than rebates and outlines the legal recourse available for entities harmed by violations of these provisions.

Additionally, the bill requires hospitals participating in the 340B program to submit an annual report to the Green Mountain Care Board detailing their participation, including estimated savings, payments to pharmacies, and how these savings benefit the community. This reporting requirement will be repealed on January 1, 2031, and the act will take effect upon passage, with the first report due by January 31, 2026.

Statutes affected:
As Introduced: 18-3631
As Passed By the House -- Official: 18-3631